DS
AZN icon

DRW Securities’s AstraZeneca AZN Stock Holding History

DRW Securities’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.65M Buy
+29,772
New +$5.6M 0.14% 110
2026
Q1 		– Sell
-25,742
Closed -$4.96M – 1287
2025
Q4 		$4.73M Sell
25,742
-6,065
-19% -$1.06M 0.13% 123
2025
Q3 		$4.89M Buy
31,807
+17,543
+123% +$2.66M 0.09% 127
2025
Q2 		$1.99M Buy
14,264
+6,658
+88% +$933K 0.05% 212
2025
Q1 		$1.12M Buy
7,606
+4,999
+192% +$723K 0.03% 249
2024
Q4 		$342K Sell
2,607
-16,127
-86% -$2.26M 0.01% 403
2024
Q3 		$2.92M Buy
18,734
+6,229
+50% +$1.01M 0.08% 123
2024
Q2 		$1.95M Buy
+12,505
New +$1.88M 0.08% 160
2024
Q1 		– Sell
-8,797
Closed -$1.18M – 382
2023
Q4 		$1.18M Buy
8,797
+3,872
+79% +$503K 0.02% 131
2023
Q3 		$667K Sell
4,925
-82,266
-94% -$11.2M 0.01% 187
2023
Q2 		$12.5M Buy
87,191
+16,212
+23% +$2.39M 0.31% 38
2023
Q1 		$9.85M Buy
70,979
+17,931
+34% +$2.41M 0.16% 53
2022
Q4 		$7.19M Buy
53,048
+50,028
+1,657% +$6.27M 0.19% 45
2022
Q3 		$331K Sell
3,020
-670
-18% -$85K 0.01% 176
2022
Q2 		$488K Sell
3,690
-9,308
-72% -$1.22M 0.01% 153
2022
Q1 		$1.73M Sell
12,998
-2,292
-15% -$275K 0.05% 102
2021
Q4 		$1.78M Sell
15,290
-1,412
-8% -$166K 0.05% 74
2021
Q3 		$2.01M Buy
16,702
+533
+3% +$62K 0.09% 77
2021
Q2 		$1.94M Hold
16,169
– – 0.06% 87
2021
Q1 		$1.61M Buy
16,169
+8,936
+124% +$898K 0.06% 67
2020
Q4 		$723K Sell
7,233
-8,206
-53% -$869K 0.03% 81
2020
Q3 		$1.69M Buy
+15,439
New +$1.72M 0.09% 58
2019
Q4 		– Sell
-10,621
Closed -$947K – 228
2019
Q3 		$947K Buy
+10,621
New +$921K 0.06% 81

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DRW Securities's AZN Position: Q2 2026 in Review

DRW Securities opened a new position in AstraZeneca (AZN) in Q2 2026: 29,772 shares worth $5.65M. The stake represents 0.14% of the portfolio and ranks #110 among its holdings. This is a return to the name: DRW Securities previously reported a position in AZN as recently as Q4 2025.

DRW Securities first reported a position in AZN in Q3 2019 and has held it in 23 quarters since. The position peaked at $12.5M in Q2 2023. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • DRW Securities held 29,772 shares of AstraZeneca worth $5.65M as of Q2 2026.
  • AstraZeneca was a new DRW Securities position in Q2 2026.
  • AstraZeneca made up 0.14% of DRW Securities's portfolio in Q2 2026, its #110 holding.
  • DRW Securities first reported a position in AstraZeneca in Q3 2019 and has held it in 23 quarters since.
  • DRW Securities's AstraZeneca position peaked at $12.5M in Q2 2023.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.